GO:0070462 plus-end specific microtubule depolymerization: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070462 (plus-end specific microtubule depolymerization) is the biological process that removes tubulin heterodimers from the plus end of a microtubule, as defined by QuickGO.
• Kinesin-8 family motors such as Kip3 in budding yeast are the best-characterized plus-end specific depolymerases, and their activity explains mitotic spindle positioning.
• Plus-end depolymerization is spatially targeted: the minus-end kinesin Kar3 is delivered to plus ends by Cik1, showing that depolymerase targeting is an active, regulated process.
• Microtubule plus-end tracking proteins (+TIPs) such as EB1 and Patronin regulate the balance between growth and plus-end depolymerization [2, 3].
• Pharmacological disruption of plus-end dynamics, for example by eribulin, blocks EB1-microtubule plus-tip complex formation and is exploited in cancer therapy [3, 8].
• Dysregulated plus-end depolymerization contributes to axonal degeneration after spinal cord injury and to mitotic defects in cancer, making it a tractable experimental target [1, 8].
Description
Microtubules are dynamic cytoskeletal polymers whose plus ends alternate between growth and shrinkage, a behavior that underlies chromosome segregation, spindle positioning, and intracellular transport [6, 7]. GO:0070462, plus-end specific microtubule depolymerization, describes the directed removal of tubulin heterodimers from the plus end of a microtubule, a process that is distinct from general catastrophe and is often catalyzed by dedicated depolymerases. Because the plus end is the primary site of microtubule interaction with kinetochores, cortical cues, and +TIP networks, controlled depolymerization at this end is essential for accurate force generation and for remodeling of the cytoskeleton during the cell cycle [4, 6]. Experimentally, plus-end specific depolymerization has been dissected using budding yeast kinesin-8 Kip3, which accumulates at plus ends and shortens microtubules in a length-dependent manner to position the mitotic spindle. In parallel, the minus-end-directed kinesin Kar3 is targeted to plus ends by Cik1, demonstrating that depolymerase delivery is spatially regulated rather than constitutive. More recent work has shown that Patronin promotes the formation of dynamic microtubule seeds in vivo, linking plus-end behavior to the broader regulation of microtubule nucleation and stability. For researchers, GO:0070462 matters because it sits at the intersection of cytoskeletal dynamics, mitosis, and neuronal regeneration. Pharmacological agents such as eribulin disrupt EB1-microtubule plus-tip complex formation, directly perturbing plus-end dynamics and providing a therapeutic handle in oncology. In spinal cord injury, cytoskeletal dysregulation including altered microtubule dynamics impairs axonal regeneration, and modulating plus-end behavior is a candidate therapeutic strategy. This article summarizes the QuickGO definition, the molecular machinery, the genes involved, and the CRISPR-based methods used to study plus-end specific microtubule depolymerization.
plus-end specific microtubule depolymerization At A Glance
| GO ID | GO:0070462 |
|---|---|
| GO term | plus-end specific microtubule depolymerization |
| Ontology | biological_process |
| Synonym | None listed in QuickGO |
| Definition | The removal of tubulin heterodimers from the plus end of a microtubule. |
| Major function | Shortening of microtubule plus ends to control spindle positioning, chromosome segregation, and cytoskeletal remodeling. |
| Key molecular players | Kinesin-8 motors (Kip3), Kar3-Cik1 complex, plus-end tracking proteins (EB1, Patronin). |
| Cellular context | Mitotic spindle, kinetochore-microtubule attachments, neuronal growth cones. |
| Disease relevance | Cancer (mitotic defects, microtubule inhibitor response), spinal cord injury and neurodegeneration. |
What Is GO:0070462?
According to QuickGO, GO:0070462 (plus-end specific microtubule depolymerization) is the biological process defined as the removal of tubulin heterodimers from the plus end of a microtubule. In other words, it is the directed shortening of a microtubule specifically at its plus end, the end that is typically more dynamic and distal from the nucleation site. This process is narrower than generic microtubule depolymerization because it specifies the plus end as the site of tubulin loss, and it is often driven by plus-end-directed motor proteins or depolymerases that accumulate at microtubule tips.
Why Is plus-end specific microtubule depolymerization Important in Cell Biology?
Plus-end specific microtubule depolymerization is important because it provides spatial control over microtubule length and force generation, which is required for accurate chromosome segregation, spindle positioning, and neuronal cytoskeletal remodeling [4, 6]. Unlike random depolymerization, plus-end specific activity allows cells to shorten microtubules at defined locations, such as kinetochores or the cell cortex, without disassembling the entire polymer. This spatial precision is exploited by microtubule-targeting drugs and is disrupted in conditions ranging from cancer to spinal cord injury, making GO:0070462 a relevant process for both basic cell biology and translational research [1, 3, 8].
• Controls mitotic spindle positioning by shortening specific microtubule plus ends, as shown for yeast Kip3.
• Enables delivery of depolymerases to plus ends via adaptor proteins such as Cik1, which targets Kar3.
• Regulates the dynamic instability of microtubules together with plus-end tracking proteins like EB1 and Patronin [2, 3].
• Is a direct target of microtubule inhibitors such as eribulin, which disrupts EB1 plus-tip complexes.
• Contributes to axonal cytoskeletal dysregulation after spinal cord injury, where microtubule dynamics are altered.
• Modulates the efficacy of microtubule inhibitors in breast cancer cells through p38-MK2 signaling.
• Provides a mechanism for length-dependent microtubule shortening that is independent of minus-end activity.
• Is conserved across eukaryotes, from yeast kinesin-8 to plant plus-end tracking proteins [5, 6].
• Influences centrosomal control of microtubule dynamics and nucleation.
• Offers a druggable node for anticancer and neuroregenerative strategies [1, 3, 8].
What Happens During plus-end specific microtubule depolymerization?
Recognition and accumulation of depolymerases at the plus end
In simple terms: First, the cell sends depolymerizing proteins to the growing tip of the microtubule.
Plus-end specific depolymerization begins with the recruitment of depolymerase motors to the microtubule plus end. The budding yeast kinesin-8 Kip3 accumulates at plus ends and its plus end-specific depolymerase activity explains its role in positioning the mitotic spindle. Similarly, the minus-end-directed kinesin Kar3 is targeted to plus ends by the adaptor Cik1, demonstrating that delivery of a depolymerase to the plus end is an active targeting step. Plus-end tracking proteins such as EB1 mark these tips and can be disrupted by drugs like eribulin, which blocks EB1-microtubule plus-tip complex formation.
Tubulin heterodimer removal at the plus end
In simple terms: Once there, the depolymerase peels tubulin building blocks off the tip.
The core event of GO:0070462 is the removal of tubulin heterodimers from the plus end of the microtubule. Kip3 exhibits plus end-specific depolymerase activity that shortens microtubules, and this activity is sufficient to explain its function in spindle positioning. This removal is directional and occurs at the plus end rather than the minus end, distinguishing it from minus-end depolymerization pathways [4, 6]. The rate and extent of tubulin loss can be modulated by plus-end tracking proteins and by the nucleotide state of tubulin within the lattice [2, 3].
Coupling to spindle positioning and chromosome segregation
In simple terms: Shortening the right microtubule tips helps the cell place its spindle and separate chromosomes.
Plus-end depolymerization is coupled to mechanical outputs such as spindle positioning. In yeast, Kip3-mediated plus-end depolymerization is required for correct positioning of the mitotic spindle. The Kar3-Cik1 complex similarly uses plus-end targeting to regulate microtubule dynamics during mitosis. These activities ensure that forces are applied at the correct subcellular location, which is essential for chromosome segregation fidelity.
Regulation by plus-end tracking proteins and nucleation factors
In simple terms: Other proteins at the tip decide whether the microtubule grows or shrinks.
Plus-end specific depolymerization does not occur in isolation; it is balanced by plus-end tracking proteins and nucleation factors. Patronin promotes the formation of dynamic microtubule seeds in vivo, linking seed formation to subsequent plus-end dynamics. EB1 tracks growing plus ends and its complex formation with microtubules is disrupted by eribulin, showing that +TIPs are regulatory nodes for plus-end behavior. Centrosomal control of microtubule dynamics further sets the context in which plus-end depolymerization operates.
Pharmacological and pathological perturbation
In simple terms: Drugs and disease states can jam or overactivate this tip-shortening process.
Plus-end specific depolymerization can be perturbed pharmacologically and in disease. Eribulin disrupts EB1-microtubule plus-tip complex formation, thereby altering plus-end dynamics. Inhibition of the p38-MK2 pathway enhances the efficacy of microtubule inhibitors in breast cancer cells, indicating that signaling pathways modulate the cellular response to plus-end perturbation. In spinal cord injury, cytoskeletal dysregulation including altered microtubule dynamics contributes to failed regeneration, highlighting the pathological relevance of plus-end depolymerization.
Key Genes Involved in GO:0070462 plus-end specific microtubule depolymerization
The following genes and proteins have been experimentally linked to plus-end specific microtubule depolymerization or to the regulation of microtubule plus-end dynamics.
| Gene | Major Role | Research Relevance |
|---|---|---|
| KIP3 | Kinesin-8 plus end-specific depolymerase in budding yeast | Defines the core enzymatic activity of GO:0070462 and spindle positioning |
| KAR3 | Minus-end-directed kinesin with depolymerase activity | Targeted to plus ends to regulate microtubule dynamics |
| CIK1 | Adaptor that targets Kar3 to microtubule plus ends | Demonstrates spatial regulation of depolymerase delivery |
| EB1 | Plus-end tracking protein (+TIP) that marks growing microtubule ends | Target of eribulin; regulates plus-tip complex formation |
| Patronin | Promotes formation of dynamic microtubule seeds | Links nucleation and plus-end dynamics in vivo |
| MAP65/AtMAP65 | Plant microtubule-associated protein tracking plus ends | Model for conserved plus-end tracking in plants |
| p38 MAPK | Stress-activated kinase modulating microtubule inhibitor response | Signaling node affecting plus-end perturbation efficacy |
| MK2 | Downstream kinase of p38 pathway | Modulates sensitivity to microtubule inhibitors |
| Tubulin alpha | Building block removed during depolymerization | Substrate of plus-end depolymerization |
| Tubulin beta | Building block removed during depolymerization | Substrate of plus-end depolymerization |
| Centrosome-associated proteins | Control microtubule nucleation and dynamics | Set the context for plus-end behavior |
| Kinesin-13 family | Microtubule depolymerases | Related depolymerases that may act at plus ends |
| XMAP215/TOG | Microtubule polymerase | Opposing activity to plus-end depolymerization |
| CLASP | Microtubule stabilizing protein | Balances plus-end dynamics |
| Katanin | Microtubule severing enzyme | Indirectly influences plus-end depolymerization |
| Spastin | Microtubule severing enzyme | Linked to neuronal microtubule dynamics |
| Dynein | Minus-end-directed motor | Contributes to microtubule organization and dynamics |
How Is plus-end specific microtubule depolymerization Regulated?
Plus-end specific microtubule depolymerization is regulated at multiple levels. Adaptor proteins such as Cik1 determine where the Kar3 depolymerase is delivered, ensuring plus-end targeting rather than random activity. Plus-end tracking proteins including EB1 and Patronin modulate the accessibility of the plus end and the formation of dynamic seeds, thereby influencing whether depolymerization can proceed [2, 3]. Signaling pathways also impinge on this process: inhibition of the p38-MK2 pathway enhances the efficacy of microtubule inhibitors in breast cancer cells, indicating that stress kinase signaling modulates the cellular response to plus-end perturbation. Centrosomal control of microtubule dynamics provides an additional layer of regulation by setting the nucleation and growth context in which plus-end depolymerization occurs.
plus-end specific microtubule depolymerization and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| KIP3 | Mitotic spindle positioning defects | Yeast knockout and point-mutation models |
| EB1 | Cancer, mitotic defects | Human cancer cell lines with EB1 knockout or tagged knock-in |
| p38/MK2 | Breast cancer drug response | Breast cancer cell lines with p38 or MK2 knockout |
| Spastin | Spinal cord injury, neurodegeneration | Neuronal cultures and animal models of spinal cord injury |
| Patronin | Developmental cytoskeletal disorders | Drosophila or mammalian cells with Patronin knockout |
Cancer and mitotic vulnerability
Plus-end specific microtubule depolymerization is central to mitotic spindle function, and its perturbation is exploited in cancer therapy. Eribulin disrupts EB1-microtubule plus-tip complex formation, directly targeting plus-end dynamics and impairing mitosis. Inhibition of the p38-MK2 pathway enhances the efficacy of microtubule inhibitors in breast cancer cells, suggesting that combining signaling inhibitors with plus-end-targeting drugs may improve outcomes. Because Kip3-family kinesin-8 motors control spindle positioning, their human orthologs are candidate targets for mitotic interference.
Spinal cord injury and neurodegeneration
Cytoskeletal dysregulation, including altered microtubule dynamics, is a hallmark of spinal cord injury and impairs axonal regeneration. Plus-end specific depolymerization contributes to the remodeling of microtubules in injured neurons, and modulating this process is a therapeutic strategy under investigation. Microtubule severing proteins such as spastin, which intersect with plus-end dynamics, have been linked to neuronal microtubule pathology.
Developmental and cytoskeletal disorders
Proper regulation of plus-end dynamics is required for cell division and morphogenesis. Patronin promotes the formation of dynamic microtubule seeds in vivo, and its function is important for organizing microtubule arrays during development. Disruption of plus-end tracking proteins such as EB1 can lead to mitotic defects and chromosomal instability, which are hallmarks of many cancers.
From plus-end specific microtubule depolymerization-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of KIP3 abolish plus-end depolymerization? | Yeast KIP3 knockout |
| How does Cik1 target Kar3 to plus ends? | CIK1 point mutations or knockout in yeast |
| Does EB1 disruption alter plus-end dynamics? | EB1 knockout or tagged knock-in in human cells |
| What is the role of Patronin in seed formation? | Patronin knockout or overexpression in Drosophila cells |
| How does p38-MK2 signaling affect microtubule inhibitor response? | p38 or MK2 knockout in breast cancer cells |
| Can plus-end depolymerization be modulated to promote regeneration? | Neuronal overexpression of depolymerases in spinal cord injury models |
How to Study the plus-end specific microtubule depolymerization Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell TIRF microscopy | Plus-end growth and shrinkage rates | Visualizing depolymerization in real time |
| Fluorescent tubulin tracking | Microtubule dynamics | Quantifying catastrophe and rescue frequencies |
| Yeast genetics (KO/point mutation) | Gene requirement for plus-end depolymerization | KIP3 and CIK1 functional studies [4, 6] |
| In vitro reconstitution | Direct depolymerase activity | Kinesin-8 mechanism |
| Drug treatment assays | Sensitivity to microtubule inhibitors | Eribulin and p38-MK2 studies [3, 8] |
| Immunofluorescence | Spindle morphology and plus-end markers | Mitotic defects in knockout cells |
| Neuronal culture imaging | Axonal microtubule dynamics | Spinal cord injury models |
| Plant cell imaging | Plus-end tracking in plants | Conserved +TIP function |
Live-cell imaging of microtubule plus ends
Live-cell imaging with fluorescently tagged tubulin and plus-end tracking proteins such as EB1 allows direct visualization of plus-end growth and shrinkage. This approach has been used to show that eribulin disrupts EB1-microtubule plus-tip complex formation and to track plus-end dynamics in plant cells. Time-lapse microscopy can quantify depolymerization rates and catastrophe frequencies.
Genetic perturbation and knockout studies
Knockout or point-mutation of depolymerase genes such as KIP3 and CIK1 in yeast has been used to demonstrate their roles in plus-end depolymerization and spindle positioning [4, 6]. In mammalian cells, knockout of EB1 or Patronin can reveal effects on plus-end dynamics and cell division [2, 3].
Biochemical reconstitution and in vitro assays
In vitro reconstitution with purified kinesin-8 motors and tubulin allows direct measurement of plus-end depolymerase activity, as shown for Kip3. Such assays can define the catalytic mechanism and the effect of nucleotide state on depolymerization.
Pharmacological and signaling perturbation
Treatment with microtubule inhibitors such as eribulin, combined with p38-MK2 pathway inhibitors, can be used to probe how signaling modulates plus-end dynamics [3, 8]. These experiments are typically performed in cancer cell lines and read out by mitotic arrest or viability assays.
How CRISPR Can Be Used to Study GO:0070462 plus-end specific microtubule depolymerization
Knockout
CRISPR knockout of genes such as KIP3, CIK1, or EB1 can abolish or reduce plus-end specific depolymerization, allowing researchers to test causality. For example, KIP3 deletion in yeast impairs spindle positioning, directly linking the gene to GO:0070462. EB1 knockout in human cells can disrupt plus-tip complex formation and mitotic progression.
Point Mutation
Point mutations in the catalytic domain of kinesin-8 motors or in the Cik1 adaptor can separate depolymerase activity from targeting. Such mutants are valuable for dissecting which residues are required for plus-end specific depolymerization versus plus-end accumulation [4, 6].
Knock-in
Knock-in of fluorescent tags (e.g., GFP) at endogenous loci of EB1, Patronin, or Kip3 enables real-time tracking of plus-end dynamics without overexpression artifacts. Tagged knock-in lines are ideal for live-cell imaging of plus-end depolymerization [2, 3].
Overexpression
Overexpression of depolymerases such as Kip3 or Kar3 can enhance plus-end depolymerization and produce dominant phenotypes, which is useful for gain-of-function studies. Overexpression of Patronin can increase dynamic seed formation and alter microtubule organization [2, 6].
How EDITGENE Supports plus-end specific microtubule depolymerization Research
Researchers studying plus-end specific microtubule depolymerization-related genes often need to determine whether a candidate gene is causally involved in tip dynamics, spindle positioning, or drug response. EDITGENE provides CRISPR-based cell model services that enable precise genetic perturbations of kinesins, +TIPs, and signaling components, from knockout to knock-in, to support mechanistic and translational studies.
Contact EDITGENE today to design your custom CRISPR model for plus-end specific microtubule depolymerization research.
Frequently Asked Questions About plus-end specific microtubule depolymerization
What is plus-end specific microtubule depolymerization?
It is the biological process GO:0070462, defined as the removal of tubulin heterodimers from the plus end of a microtubule, as described in QuickGO.
What genes are involved in plus-end specific microtubule depolymerization?
Key genes include KIP3, KAR3, CIK1, EB1, and Patronin, which encode kinesin motors and plus-end tracking proteins that regulate microtubule tip dynamics [2, 3, 4, 6].
How does Kip3 depolymerize microtubule plus ends?
Kip3 is a kinesin-8 with plus end-specific depolymerase activity that shortens microtubules and positions the yeast mitotic spindle.
What is the role of EB1 in microtubule plus-end dynamics?
EB1 is a plus-end tracking protein that marks growing microtubule tips; eribulin disrupts EB1-microtubule plus-tip complex formation, altering plus-end dynamics.
How is Kar3 targeted to microtubule plus ends?
The adaptor protein Cik1 targets the minus-end kinesin Kar3 to microtubule plus ends, where it regulates depolymerization.
What diseases are linked to plus-end microtubule depolymerization?
Cancer and spinal cord injury are linked; microtubule inhibitors such as eribulin target plus-end dynamics, and cytoskeletal dysregulation impairs regeneration after spinal cord injury [1, 3, 8].
Can CRISPR be used to study plus-end specific microtubule depolymerization?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can be used to dissect gene function in this process [2, 3, 4, 6].
What methods measure plus-end specific microtubule depolymerization?
Live-cell imaging, in vitro reconstitution, and genetic perturbation assays are commonly used to measure plus-end depolymerization rates and effects [3, 5, 6].
What is the difference between plus-end and minus-end depolymerization?
Plus-end specific depolymerization removes tubulin from the plus end, while minus-end depolymerization acts at the opposite end; Kar3 is a minus-end motor that can be targeted to plus ends by Cik1 [4, 6].
How does p38-MK2 signaling affect microtubule inhibitors?
Inhibition of the p38-MK2 pathway enhances the efficacy of microtubule inhibitors in breast cancer cells, linking signaling to plus-end perturbation responses.
Conclusion
GO:0070462, plus-end specific microtubule depolymerization, is a spatially precise biological process that removes tubulin heterodimers from microtubule plus ends. It is driven by kinesin-8 motors such as Kip3 and regulated by adaptors like Cik1 and plus-end tracking proteins such as EB1 and Patronin [2, 3, 4, 6]. Its importance spans mitotic spindle positioning, cancer drug response, and neuronal regeneration after spinal cord injury [1, 3, 8]. Continued research using CRISPR models and live-cell imaging will clarify how this process is controlled and how it can be therapeutically modulated.
References
- 1. Fischer I et al.. 2026. Microtubules in Spinal Cord Injury: From Cytoskeletal Dysregulation to Therapeutic Regeneration.. J Neurochem 170(8):e70537 PMID: 42563243
- 2. Shen Y et al.. 2026. Patronin promotes the formation of dynamic microtubule seeds in vivo.. J Cell Sci 139(14) PMID: 42253036
- 3. O'Rourke B et al.. 2014. Eribulin disrupts EB1-microtubule plus-tip complex formation.. Cell Cycle 13(20):3218-21 PMID: 25485501
- 4. Sproul LR et al.. 2005. Cik1 targets the minus-end kinesin depolymerase kar3 to microtubule plus ends.. Curr Biol 15(15):1420-7 PMID: 16085496
- 5. Wong JH et al.. 2017. Novel Arabidopsis microtubule-associated proteins track growing microtubule plus ends.. BMC Plant Biol 17(1):33 PMID: 28148225
- 6. Gupta ML Jr et al.. 2006. Plus end-specific depolymerase activity of Kip3, a kinesin-8 protein, explains its role in positioning the yeast mitotic spindle.. Nat Cell Biol 8(9):913-23 PMID: 16906148
- 7. Rodionov V et al.. 1999. Centrosomal control of microtubule dynamics.. Proc Natl Acad Sci U S A 96(1):115-20 PMID: 9874781
- 8. Chen YC et al.. 2025. Inhibition of p38-MK2 pathway enhances the efficacy of microtubule inhibitors in breast cancer cells.. Elife 13 PMID: 40439108
